Marketing-authorisation holder
Endocyte Europe, B.V.
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Folcepri | Etarfolatide | EU (EMA) | Refused | |
| Neocepri | Folic acid | EU (EMA) | Refused | |
| Vynfinit | EU (EMA) | Refused |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| European Union (EMA) | 3 | 0 | 3 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- endocyte europe
- endocyte europe b v
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
European Medicines Agency
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder